Stay updated on Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial
Sign up to get notified when there's something new on the Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial page.

Latest updates to the Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page displays a new revision label (v3.4.2) and removal of the previous label (v3.4.0). There are no changes to the study details or user-facing content.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedExpanded the study locations with numerous new site entries across US states and international regions (e.g., New South Wales, Ontario, Greater London) and removed certain existing location entries as part of revision 3.3.3.SummaryDifference2%

- Check91 days agoChange DetectedMinor textual updates to the PubMed publications display (auto-fill note) and to revision/version labels (v3.3.2, v3.2.0), with no impact on the study content or user tasks. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check98 days agoChange DetectedAdministrative notice about government funding status and operating updates was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check120 days agoChange DetectedMinor UI/layout adjustments to the Study Details page (spacing and section arrangement) with no changes to core content such as conditions, interventions, outcomes, or eligibility criteria.SummaryDifference0.3%

Stay in the know with updates to Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial page.